MaxCyte, Inc. (MXCT)
NASDAQ: MXCT · Real-Time Price · USD
1.380
+0.110 (8.66%)
At close: Aug 13, 2025, 4:00 PM
1.500
+0.120 (8.70%)
Pre-market: Aug 14, 2025, 9:17 AM EDT
MaxCyte Employees
MaxCyte had 114 employees as of December 31, 2024. The number of employees decreased by 29 or -20.28% compared to the previous year.
Employees
114
Change (1Y)
-29
Growth (1Y)
-20.28%
Revenue / Employee
$313,632
Profits / Employee
-$392,737
Market Cap
147.12M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
MXCT News
- 7 days ago - MaxCyte, Inc. (MXCT) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 10 days ago - MaxCyte Signs Platform License Agreement with Adicet Bio - GlobeNewsWire
- 14 days ago - MaxCyte Announces Strategic Platform Licensing Agreement with Anocca AB to Advance TCR-T Cell Therapy Pipeline - GlobeNewsWire
- 5 weeks ago - MaxCyte to Report Second Quarter 2025 Financial Results on August 6, 2025 - GlobeNewsWire
- 6 weeks ago - PHC Announces Exclusive Distribution of MaxCyte® ExPERT™ Platform in Japan - Business Wire
- 2 months ago - MaxCyte and Ori Biotech Collaborate to Improve Manufacturing Efficiencies and Broaden Adoption of Autologous Cellular Therapies - GlobeNewsWire
- 3 months ago - MaxCyte, Inc. (MXCT) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - MaxCyte Reports First Quarter 2025 Financial Results and Reiterates Full Year 2025 Guidance - GlobeNewsWire